Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Apr;62(4):834–841. doi: 10.1086/301803

A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene.

E Ars 1, H Kruyer 1, A Gaona 1, P Casquero 1, J Rosell 1, V Volpini 1, E Serra 1, C Lázaro 1, X Estivill 1
PMCID: PMC1377042  PMID: 9529361

Abstract

Spinal neurofibromatosis (SNF) has been considered to be an alternative form of neurofibromatosis in which spinal cord tumors are the main clinical characteristic. Familial SNF has been reported, elsewhere, in three families-two linked to markers within the gene for neurofibromatosis type 1 (NF1) and the other not linked to NF1-but no molecular alterations have been described in these families. We describe a three-generation family that includes five members affected by SNF. All the affected members presented multiple spinal neurofibromas and café au lait spots, one member had cutaneous neurofibromas, and some members had other signs of NF1. Genetic analysis, performed with markers within and flanking the NF1 gene, showed segregation with the NF1 locus. Mutation analysis, performed with the protein-truncation test and SSCP/heteroduplex analysis of the whole coding region of the NF1 gene, identified a frameshift mutation (8042insA) in exon 46, which should result in a truncated NF1 protein. The 8042insA mutation was detected in all five family members with the SNF/NF1 phenotype. To our knowledge, this is the first time that a mutation in the NF1 gene has been associated with SNF. The clinical homogeneity in the severity of the disease among the affected members of the family, which is unusual in NF1, suggests that a particular property of the NF1 mutation described here, a gene closely linked to NF1, or posttranscriptional events are involved in this severe neurological phenotype.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeliovich D., Gelman-Kohan Z., Silverstein S., Lerer I., Chemke J., Merin S., Zlotogora J. Familial café au lait spots: a variant of neurofibromatosis type 1. J Med Genet. 1995 Dec;32(12):985–986. doi: 10.1136/jmg.32.12.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahlbom B. E., Dahl N., Zetterqvist P., Annerén G. Noonan syndrome with café-au-lait spots and multiple lentigines syndrome are not linked to the neurofibromatosis type 1 locus. Clin Genet. 1995 Aug;48(2):85–89. doi: 10.1111/j.1399-0004.1995.tb04061.x. [DOI] [PubMed] [Google Scholar]
  3. Andersen L. B., Fountain J. W., Gutmann D. H., Tarlé S. A., Glover T. W., Dracopoli N. C., Housman D. E., Collins F. S. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet. 1993 Feb;3(2):118–121. doi: 10.1038/ng0293-118. [DOI] [PubMed] [Google Scholar]
  4. Bahuau M., Flintoff W., Assouline B., Lyonnet S., Le Merrer M., Prieur M., Guilloud-Bataille M., Feingold N., Munnich A., Vidaud M. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association. Am J Med Genet. 1996 Dec 18;66(3):347–355. doi: 10.1002/(SICI)1096-8628(19961218)66:3<347::AID-AJMG20>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  5. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 1990 Nov 16;63(4):851–859. doi: 10.1016/0092-8674(90)90151-4. [DOI] [PubMed] [Google Scholar]
  6. Bourn D., Strachan T. Highly polymorphic dinucleotide repeat at the NF2 gene. Hum Genet. 1995 Jun;95(6):712–712. doi: 10.1007/BF00209494. [DOI] [PubMed] [Google Scholar]
  7. Brunner H. G., Hulsebos T., Steijlen P. M., der Kinderen D. J., vd Steen A., Hamel B. C. Exclusion of the neurofibromatosis 1 locus in a family with inherited café-au-lait spots. Am J Med Genet. 1993 Jun 1;46(4):472–474. doi: 10.1002/ajmg.1320460428. [DOI] [PubMed] [Google Scholar]
  8. Cawthon R. M., Weiss R., Xu G. F., Viskochil D., Culver M., Stevens J., Robertson M., Dunn D., Gesteland R., O'Connell P. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990 Jul 13;62(1):193–201. doi: 10.1016/0092-8674(90)90253-b. [DOI] [PubMed] [Google Scholar]
  9. Colman S. D., Williams C. A., Wallace M. R. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet. 1995 Sep;11(1):90–92. doi: 10.1038/ng0995-90. [DOI] [PubMed] [Google Scholar]
  10. Danglot G., Régnier V., Fauvet D., Vassal G., Kujas M., Bernheim A. Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene. Hum Mol Genet. 1995 May;4(5):915–920. doi: 10.1093/hmg/4.5.915. [DOI] [PubMed] [Google Scholar]
  11. Heim R. A., Kam-Morgan L. N., Binnie C. G., Corns D. D., Cayouette M. C., Farber R. A., Aylsworth A. S., Silverman L. M., Luce M. C. Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet. 1995 Jun;4(6):975–981. doi: 10.1093/hmg/4.6.975. [DOI] [PubMed] [Google Scholar]
  12. Hoffmeyer S., Assum G., Kaufmann D., Schwenk K., Krone W. A deletion in the 5'-region of the neurofibromatosis type 1 (NF1) gene. Hum Genet. 1994 Jul;94(1):97–100. doi: 10.1007/BF02272852. [DOI] [PubMed] [Google Scholar]
  13. Huson S. M., Harper P. S., Compston D. A. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988 Dec;111(Pt 6):1355–1381. doi: 10.1093/brain/111.6.1355. [DOI] [PubMed] [Google Scholar]
  14. Kayes L. M., Burke W., Riccardi V. M., Bennett R., Ehrlich P., Rubenstein A., Stephens K. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet. 1994 Mar;54(3):424–436. [PMC free article] [PubMed] [Google Scholar]
  15. Legius E., Marchuk D. A., Collins F. S., Glover T. W. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet. 1993 Feb;3(2):122–126. doi: 10.1038/ng0293-122. [DOI] [PubMed] [Google Scholar]
  16. Leppig K. A., Viskochil D., Neil S., Rubenstein A., Johnson V. P., Zhu X. L., Brothman A. R., Stephens K. The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization. Cytogenet Cell Genet. 1996;72(1):95–98. doi: 10.1159/000134171. [DOI] [PubMed] [Google Scholar]
  17. Li Y., Bollag G., Clark R., Stevens J., Conroy L., Fults D., Ward K., Friedman E., Samowitz W., Robertson M. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell. 1992 Apr 17;69(2):275–281. doi: 10.1016/0092-8674(92)90408-5. [DOI] [PubMed] [Google Scholar]
  18. Li Y., O'Connell P., Breidenbach H. H., Cawthon R., Stevens J., Xu G., Neil S., Robertson M., White R., Viskochil D. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics. 1995 Jan 1;25(1):9–18. doi: 10.1016/0888-7543(95)80104-t. [DOI] [PubMed] [Google Scholar]
  19. Luna E. J., Hitt A. L. Cytoskeleton--plasma membrane interactions. Science. 1992 Nov 6;258(5084):955–964. doi: 10.1126/science.1439807. [DOI] [PubMed] [Google Scholar]
  20. Lázaro C., Gaona A., Ravella A., Volpini V., Casals T., Fuentes J. J., Estivill X. Novel alleles, hemizygosity and deletions at an Alu-repeat within the neurofibromatosis type 1 (NF1) gene. Hum Mol Genet. 1993 Jun;2(6):725–730. doi: 10.1093/hmg/2.6.725. [DOI] [PubMed] [Google Scholar]
  21. Marineau C., Baron C., Delattre O., Zucman J., Thomas G., Rouleau G. A. Dinucleotide repeat polymorphism at the D22S268 locus. Hum Mol Genet. 1993 Mar;2(3):336–336. doi: 10.1093/hmg/2.3.336-a. [DOI] [PubMed] [Google Scholar]
  22. Martin G. A., Viskochil D., Bollag G., McCabe P. C., Crosier W. J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R. M. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990 Nov 16;63(4):843–849. doi: 10.1016/0092-8674(90)90150-d. [DOI] [PubMed] [Google Scholar]
  23. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988 May;45(5):575–578. [PubMed] [Google Scholar]
  25. Poyhonen M., Leisti E. L., Kytölä S., Leisti J. Hereditary spinal neurofibromatosis: a rare form of NF1? J Med Genet. 1997 Mar;34(3):184–187. doi: 10.1136/jmg.34.3.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pulst S. M., Riccardi V. M., Fain P., Korenberg J. R. Familial spinal neurofibromatosis: clinical and DNA linkage analysis. Neurology. 1991 Dec;41(12):1923–1927. doi: 10.1212/wnl.41.12.1923. [DOI] [PubMed] [Google Scholar]
  27. Pulst S. M., Riccardi V., Mautner V. Spinal schwannomatosis. Neurology. 1997 Mar;48(3):787–788. doi: 10.1212/wnl.48.3.787. [DOI] [PubMed] [Google Scholar]
  28. Rouleau G. A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993 Jun 10;363(6429):515–521. doi: 10.1038/363515a0. [DOI] [PubMed] [Google Scholar]
  29. Sawada S., Florell S., Purandare S. M., Ota M., Stephens K., Viskochil D. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet. 1996 Sep;14(1):110–112. doi: 10.1038/ng0996-110. [DOI] [PubMed] [Google Scholar]
  30. Serra E., Puig S., Otero D., Gaona A., Kruyer H., Ars E., Estivill X., Lázaro C. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet. 1997 Sep;61(3):512–519. doi: 10.1086/515504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Shannon K. M., O'Connell P., Martin G. A., Paderanga D., Olson K., Dinndorf P., McCormick F. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med. 1994 Mar 3;330(9):597–601. doi: 10.1056/NEJM199403033300903. [DOI] [PubMed] [Google Scholar]
  32. Skuse G. R., Cappione A. J. RNA processing and clinical variability in neurofibromatosis type I (NF1). Hum Mol Genet. 1997;6(10):1707–1712. doi: 10.1093/hmg/6.10.1707. [DOI] [PubMed] [Google Scholar]
  33. Tassabehji M., Strachan T., Sharland M., Colley A., Donnai D., Harris R., Thakker N. Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet. 1993 Jul;53(1):90–95. [PMC free article] [PubMed] [Google Scholar]
  34. The I., Murthy A. E., Hannigan G. E., Jacoby L. B., Menon A. G., Gusella J. F., Bernards A. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet. 1993 Jan;3(1):62–66. doi: 10.1038/ng0193-62. [DOI] [PubMed] [Google Scholar]
  35. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993 Mar 12;72(5):791–800. doi: 10.1016/0092-8674(93)90406-g. [DOI] [PubMed] [Google Scholar]
  36. Upadhyaya M., Roberts S. H., Maynard J., Sorour E., Thompson P. W., Vaughan M., Wilkie A. O., Hughes H. E. A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay. J Med Genet. 1996 Feb;33(2):148–152. doi: 10.1136/jmg.33.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver M., Carey J. C., Copeland N. G., Jenkins N. A. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990 Jul 13;62(1):187–192. doi: 10.1016/0092-8674(90)90252-a. [DOI] [PubMed] [Google Scholar]
  38. Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M., Fountain J. W., Brereton A., Nicholson J., Mitchell A. L. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990 Jul 13;249(4965):181–186. doi: 10.1126/science.2134734. [DOI] [PubMed] [Google Scholar]
  39. Wu B. L., Austin M. A., Schneider G. H., Boles R. G., Korf B. R. Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations. Am J Med Genet. 1995 Dec 4;59(4):528–535. doi: 10.1002/ajmg.1320590427. [DOI] [PubMed] [Google Scholar]
  40. Wu B. L., Schneider G. H., Korf B. R. Deletion of the entire NF1 gene causing distinct manifestations in a family. Am J Med Genet. 1997 Mar 3;69(1):98–101. [PubMed] [Google Scholar]
  41. Wu R., Legius E., Robberecht W., Dumoulin M., Cassiman J. J., Fryns J. P. Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome. Hum Mutat. 1996;8(1):51–56. doi: 10.1002/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  42. Xu G. F., Lin B., Tanaka K., Dunn D., Wood D., Gesteland R., White R., Weiss R., Tamanoi F. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell. 1990 Nov 16;63(4):835–841. doi: 10.1016/0092-8674(90)90149-9. [DOI] [PubMed] [Google Scholar]
  43. Xu G. F., O'Connell P., Viskochil D., Cawthon R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990 Aug 10;62(3):599–608. doi: 10.1016/0092-8674(90)90024-9. [DOI] [PubMed] [Google Scholar]
  44. Xu W., Mulligan L. M., Ponder M. A., Liu L., Smith B. A., Mathew C. G., Ponder B. A. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer. 1992 Jun;4(4):337–342. doi: 10.1002/gcc.2870040411. [DOI] [PubMed] [Google Scholar]
  45. von Deimling A., Krone W., Menon A. G. Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol. 1995 Apr;5(2):153–162. doi: 10.1111/j.1750-3639.1995.tb00589.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES